Danielle Boyle: ITP Australia and New Zealand Patient Conference to Connect Patients, Families, and Experts
Danielle Boyle, Founder and CEO of ITP Australia and New Zealand, reposted from ITP Australia and New Zealand on LinkedIn:
”The annual ITP Australia and New Zealand Patient Conference is the anchor of our calendar, and it’s hard to believe we’re now less than a month away.
This year, we’ll gather at Melbourne Town Hall on Saturday, 7 March 2026, joined by an exceptional group of medical and scientific leaders who are deeply committed to advancing care and understanding for people living with Immune Thrombocytopenia.
What stays with me every year is the collective Exhale from patients and families as they realise they’re surrounded by people who genuinely understand their journey.
It’s a moment of recognition, relief, and connection — a reminder that no one has to navigate ITP alone.
We warmly welcome our industry partners, healthcare professionals, researchers, and anyone with an interest in ITP to join us.
It’s an opportunity to hear directly from the community, understand the questions that matter most to patients, and experience the impact of bringing lived experience and clinical expertise together.
Grab your tickets today.”
Quoting ITP Australia and New Zealand‘s post:
”One month until the ITPANZ Annual Patient Conference in Melbourne.
This event brings together patients, families, clinicians, and researchers for a day of education, discussion, and shared insight into Immune Thrombocytopenia.
The program includes expert presentations, treatment updates, and lived‑experience perspectives designed to support informed, patient‑centred care.

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series